Most cited papers from Metaxa Hospital

Metaxa Hospital

What are the most cited papers from Metaxa Hospital?

The most cited paper from Metaxa Hospital is "Immunotherapy for pancreatic cancer: A 2020 update" (Dimitriοs Schizas, Nikolaos Charalampakis, Christo Kole et al., 2020), with 513 citations. Next come "Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study" (444) and "FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)" (405).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 74 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Immunotherapy for pancreatic cancer: A 2020 update Dimitriοs Schizas, Nikolaos Charalampakis, Christo Kole et al. · Cancer Treatment Reviews	25 Mar 2020	513
2	Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study John D Spiliotis, Evgenia Halkia, Evangelos Lianos et al. · Annals of Surgical Oncology	12 Nov 2014	444
3	FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG) John Souglakos, Nicos Androulakis, Konstantinos N. Syrigos et al. · British Journal of Cancer Open access	28 Feb 2006	405
4	Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study Christos Kosmas, Manolis S. Kallistratos, Petros Kopterides et al. · Journal of Cancer Research and Clinical Oncology Open access	17 Jul 2007	335
5	Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases Dosia Antonadou, M. Paraskevaidis, George E. Sarris et al. · Journal of Clinical Oncology	29 Aug 2002	332
6	Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis Nikos Oikonomou, Marios-Angelos Mouratis, Argyris Tzouvelekis et al. · American Journal of Respiratory Cell and Molecular Biology	29 Jun 2012	260
7	Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer Dosia Antonadou, Marizenia Pepelassi, Maria Synodinou et al. · International Journal of Radiation OncologyBiologyPhysics	Mar 2002	242
8	Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials Jeremy P. Braybrooke et al. · The Lancet ReviewOpen access236 authors	Apr 2023	210
9	Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer Dosia Antonadou, Nikos Coliarakis, Maria Synodinou et al. · International Journal of Radiation OncologyBiologyPhysics	Nov 2001	203
10	Diet and breast cancer: A case‐control study in Greece Klea Katsouyanni, D. Trichopoulos, Peter A. Boyle et al. · International Journal of Cancer	15 Dec 1986	190
11	A new tumor suppressor role for the Notch pathway in bladder cancer Theodoros N Rampias, Paraskevi Vgenopoulou, Margaritis Avgeris et al. · Nature Medicine	7 Sep 2014	186
12	Central nervous system metastases of choriocarcinoma. 23 Years' experience at Charing Cross Hospital A. Athanassiou, Richard H. J. Beǵent, Edward S. Newlands et al. · Cancer	Nov 1983	183
13	"Timed Up & Go": A Screening Tool for Predicting 30-Day Morbidity in Onco-Geriatric Surgical Patients? A Multicenter Cohort Study Monique G. Huisman, Barbara L. van Leeuwen, Giampaolo Ugolini et al. · PLoS ONE Open access	24 Jan 2014	178
14	Cancer screening in the European Union Azucena Aldaz et al. · European Journal of Cancer	1994	178
15	Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases C. Christodoulou, Dimitrios I. Bafaloukos, P. Kosmidis et al. · Annals of Oncology Open access	Feb 2001	175
16	Oncology during the COVID‑19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients (Review) Konstantinos Tsamakis, Maria Gavriatopoulou, Dimitriοs Schizas et al. · Oncology Letters Open access	8 May 2020	166
17	Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG) D. Mavroudis, Emmanouil S. Saloustros, Nicholaos A. Malamos et al. · Annals of Oncology Open access	2 May 2015	165
18	Vitamin D and glycemic control in diabetes mellitus type 2 Ifigenia Kostoglou‐Athanassiou, Panagiotis Athanassiou, Anastasios Gkountouvas et al. · Therapeutic Advances in Endocrinology and Metabolism Open access	Aug 2013	165
19	Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease Nour Kibbi et al. · JAMA Oncology Open access	20 Jan 2022	163
20	The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery Arancha Prada-Villaverde et al. · Journal of Surgical Oncology Open access	2 Aug 2014	162
21	Immunotherapy for Hepatocellular Carcinoma: A 2021 Update Christo Kole, Nikolaos Charalampakis, Sergios A. Tsakatikas et al. · Cancers Open access	4 Oct 2020	159
22	The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis Jesús Esquivel et al. · Annals of Surgical Oncology Open access	22 May 2014	155
23	Antimicrobial activity of essential oils of cultivated oregano (Origanum vulgare), sage (Salvia officinalis), and thyme (Thymus vulgaris) against clinical isolates ofEscherichia coli,Klebsiella oxytoca, andKlebsiella pneumoniae Maria Fournomiti, Athanasios C. Kimbaris, Ioanna Mantzourani et al. · Microbial Ecology in Health and Disease Open access	15 Apr 2015	149
24	Soluble TNF Mediates the Transition from Pulmonary Inflammation to Fibrosis Nikos Oikonomou, Vaggelis Harokopos, Jonathan Zalevsky et al. · PLoS ONE Open access	26 Dec 2006	136
25	Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study Efstathios Kastritis, Maria Gavriatopoulou, Marie‐Christine Kyrtsonis et al. · Blood Open access	10 Sep 2015	134
26	Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care Theodoros P. Vassilakopoulos et al. · The Oncologist Open access	26 Jan 2012	124
27	GNRI as a Prognostic Factor for Outcomes in Cancer Patients: A Systematic Review of the Literature Irene Lidoriki, Dimitriοs Schizas, Maximos Frountzas et al. · Nutrition and Cancer Review	23 Apr 2020	121
28	Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force Ian H Kunkler, Riccardo Alberto Audisio, Yazid Belkacémi et al. · Annals of Oncology Open access	13 Mar 2014	121
29	Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial Helen Athanassiou, Dosia Antonadou, Nikos Coliarakis et al. · International Journal of Radiation OncologyBiologyPhysics	30 Jun 2003	119
30	ESMO takes a stand on supportive and palliative care Nathan I. Cherny, R. Catane, P. Kosmidis et al. · Annals of Oncology Open access	Sep 2003	118
31	A revised international prognostic score system for Waldenström’s macroglobulinemia Efstathios Kastritis et al. · Leukemia	22 May 2019	116
32	A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies Maria N. Gamaletsou et al. · Clinical Microbiology and Infection Open access	25 Jun 2013	112
33	Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study Nicolas B. Tsavaris, Christos Kosmas, Helias Skopelitis et al. · Investigational New Drugs	12 Jul 2005	105
34	Gemcitabine and oxaliplatin (GEMOX) in patients withcisplatin-refractory germ cell tumors: a phase II study Dimitris Pectasides, Melina Pectasides, Dimitrios T. Farmakis et al. · Annals of Oncology Open access	Mar 2004	104
35	Diagnosis and Management of Peritoneal Metastases from Ovarian Cancer Evgenia Halkia, John D Spiliotis, Paul Hendrick Sugarbaker · Gastroenterology Research and Practice Open access	2012	104
36	Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer Giannis Mountzios et al. · ESMO Open Open access	Sep 2021	102
37	Screening for predictors of adverse outcome in onco-geriatric surgical patients: A multicenter prospective cohort study Monique G. Huisman, Riccardo Alberto Audisio, Giampaolo Ugolini et al. · European Journal of Surgical Oncology Open access	15 Apr 2015	102
38	Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide Gregory B. Sivolapenko, Demosthenis Skarlos, Demitris Pectasides et al. · European Journal of Nuclear Medicine and Molecular Imaging	29 Sep 1998	101
39	HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy George Fountzilas et al. · Journal of Translational Medicine Open access	12 Jan 2012	100
40	Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer Nicolas Mylonakis, A E Athanasiou, Nikolaos Ziras et al. · Lung Cancer	23 Jul 2009	97
41	Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non–small-cell lung cancer Dosia Antonadou, Nikolas Throuvalas, Aris Petridis et al. · International Journal of Radiation OncologyBiologyPhysics Open access	12 Sep 2003	97
42	Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study Helen Giamarellou, Evangelos J. Giamarellos‐Bourboulis, Panagiotis Repoussis et al. · Clinical Microbiology and Infection Open access	24 Jun 2004	97
43	Pancoast tumors: characteristics and preoperative assessment. Νικόλαος Παναγόπουλος, Vasilios Leivaditis, Efstratios N. Koletsis et al. · PubMed Open access	Mar 2014	95
44	Videolaryngoscopy in the management of the difficult airway: a comparison with the Macintosh blade Konstantinos Stroumpoulis, Alexandra Pagoulatou, Magda Violari et al. · European Journal of Anaesthesiology	23 Feb 2009	93
45	CEA, CA 19-9, and CA-50 in Monitoring Gastric Carcinoma Dimitrios G. Pectasides, Alexander Mylonakis, Mary Kostopoulou et al. · American Journal of Clinical Oncology	Aug 1997	92
46	Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials. P. Kosmidis, Epaminodas Samantas, George Fountzilas et al. · PubMed	Jun 1994	88
47	Effect of Primary Hyperparathyroidism on Volumetric Bone Mineral Density and Bone Geometry Assessed by Peripheral Quantitative Computed Tomography in Postmenopausal Women Ioannis Charopoulos, Symeon Tournis, George Trovas et al. · The Journal of Clinical Endocrinology & Metabolism Open access	22 Feb 2006	87
48	Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases Polydoros Tofas, Anna Skiada, Maria K. Angelopoulou et al. · International Journal of Antimicrobial Agents	27 Feb 2016	86
49	Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial Dimitris Pectasides, Melina Pectasides, Dimitrios T. Farmakis et al. · Annals of Oncology Open access	24 Jan 2005	85
50	Diagnosis and management of parathyroid carcinoma: a state-of-the-art review Pia Roser, Bianca Maria Leca, Cláudia Matta-Coelho et al. · Endocrine Related Cancer Open access	9 Jan 2023	82

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.